Clinical Study Protocol Template – ICH-GCP R3 Compliant & Global Regulatory-Ready

Develop submission-ready, inspection-ready clinical trial protocols with confidence using this comprehensive Clinical Study Protocol Template, fully aligned with the latest International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH-GCP E6 R3) guidelines and global regulatory expectations.

Designed for modern clinical research environments, this template supports compliance with:

• European Medicines Agency (EMA)

• Food and Drug Administration (US FDA)

• Central Drugs Standard Control Organization (CDSCO – India)

• Global Ethics Committees & IRBs

Whether you are drafting a Phase I–IV interventional study, observational study, post-marketing study, or investigator-initiated research, this template ensures structure, compliance, and regulatory clarity.

What Makes This Template Valuable?

✔ Fully structured from Synopsis to Appendices
✔ Built in accordance with ICH-GCP E6 R3 principles
✔ Risk-based Quality Management aligned with modern GCP expectations
✔ Detailed AE/SAE Definitions & Safety Reporting Framework
✔ Statistical Considerations & Sample Size Justification Section
✔ Monitoring & Quality Assurance Framework
✔ Ethics, IRB/IEC & Informed Consent Sections
✔ Data Handling, Record Retention & Publication Policy
✔ Schedule of Events Table Included
✔ Abbreviation Management & Regulatory Formatting Guidance
✔ Ready for Global Regulatory Submission

Designed For

• Contract Research Organizations (CROs)

• Pharmaceutical & Biotech Companies

• Regulatory Affairs Professionals

• Medical Writers

• Academic Investigators

• Clinical Research Students

Why You Need This Template

✔ Reduces protocol development time significantly
✔ Minimizes regulatory gaps under ICH-GCP R3
✔ Supports risk-based quality management approach
✔ Improves sponsor, auditor, and reviewer confidence
✔ Enhances inspection readiness
✔ Supports multi-country regulatory submissions

This product is delivered in fully editable Microsoft Word (.DOCX) format, allowing complete customization according to study phase, therapeutic area, and sponsor requirements.